Research

The Future of Pharmaceuticals for Human Use in Europe

The European pharmaceutical industry makes an irreplaceable contribution to Europe's wellbeing through the availability of medicines, economic growth and employment. The pharmaceutical sector has been and remains a key strategic sector for Europe.

Study Trends Online Professional Activities and Reveals Specialty-specific Marketing Opportunities

Manhattan Research, a healthcare market research services firm, announced the leading pharmaceutical product website destinations for physicians from its new physician research study, "ePharma Physician® v7.0: The Future of Professional eMarketing.". Manhattan Research recently hosted a webcast discussing highlights of the ePharma Physician® v7.0 research.

Putnam Associates Study Finds Insurers Want More Prescription Drug Use

Putnam Associates released today the results of an intensive study of U.S. health insurance plans' perceptions of branded prescription drug use in the U.S. The study revealed that plans believe greater pharmacoeconomic value can be unlocked by increasing patient use within certain drug categories.

Patients and Healthcare Providers to Experience Significant Benefits from the Use of the Internet

The growth of Internet applications in healthcare has been rapid. A growing number of patients are becoming increasingly involved in the healthcare service they receive. These 'power patients' possess characteristics that distinguish them from traditional patients and are an important factor in driving the use of the Internet in healthcare.

Merck's Investigational Integrase Inhibitor for HIV

Merck & Co., Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for ISENTRESS™ (raltegravir, previously known as MK-0518). Data in the NDA support the proposed use of ISENTRESS in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-experienced patients with evidence of HIV-1 replication despite ongoing antiretroviral therapy (ART).

The Future of Pharmaceuticals for Human Use in Europe

Study Trends Online Professional Activities and Reveals Specialty-specific Marketing Opportunities

Putnam Associates Study Finds Insurers Want More Prescription Drug Use

Patients and Healthcare Providers to Experience Significant Benefits from the Use of the Internet

Merck's Investigational Integrase Inhibitor for HIV

Business & Industry

Research & Development

Conferences & Events

Regulatory Affairs